0001562180-20-004079.txt : 20200602 0001562180-20-004079.hdr.sgml : 20200602 20200602171354 ACCESSION NUMBER: 0001562180-20-004079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200522 FILED AS OF DATE: 20200602 DATE AS OF CHANGE: 20200602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIENS HAROLD J CENTRAL INDEX KEY: 0001197788 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 20938022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-05-22 false 0000842023 BIO-TECHNE Corp TECH 0001197788 WIENS HAROLD J 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 true false false false Common Stock 2020-05-22 4 G false 378.00 0.00 D 4843.00 D Common Stock 2020-05-29 4 M false 3985.00 101.19 A 8828.00 D Common Stock 2020-05-29 4 S false 3985.00 260.00 D 4843.00 D Stock Option (Right to Buy) 101.19 2020-05-29 4 M false 3985.00 0.00 D 2017-10-26 2026-10-27 Common Stock 3985.00 0.00 D Stock Option (right to buy) 201.64 2029-10-24 Common Stock 2011.00 2011.00 D Stock Option (right to buy) 179.84 2019-10-24 2028-10-25 Common Stock 1898.00 1898.00 D Stock Option (right to buy) 125.05 2018-10-25 2027-10-26 Common Stock 3125.00 3125.00 D Stock Option (Right to Buy) 87.34 2016-10-29 2025-10-28 Common Stock 4260.00 4260.00 D Stock Options (Right to buy) 125.05 2018-10-25 2027-10-26 Common Stock 3125.00 3125.00 D Stock Options (Right to Buy) 91.78 2014-10-30 2024-10-30 Common Stock 4000.00 4000.00 D Stock Options (Right to Buy) 87.83 2014-05-15 2024-05-15 Common Stock 2000.00 2000.00 D Represents a transfer of shares to a charitable donor advised fund. The reporting person retained no pecuniary interest in the transferred shares. The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne 2020 annual meeting of shareholders. /s/ Brenda S. Furlow, attorney in fact for Harold J. Wiens pursuant to Power of Attorney previously filed 2020-06-02 EX-24 2 wienspoa2018.txt WIENS POWER OF ATTORNEY POWER OF ATTORNEY The undersigned hereby constitutes and appoints Brenda S. Furlow, James Hippel, Anna Weispfenning, Melodie R. Rose, Andrew Nick, Sarah Tucher or either of them acting alone, the undersigned's true and lawful attorneys- in-fact and agent with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place and stead, in any and all capacities, to sign any or all Forms 3, Forms 4 and Forms 5 relating to beneficial ownership of securities of Bio-Techne Corporation (the "Issuer"), to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission and to deliver a copy of the same to the Issuer, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all said attorneys-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue thereof. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in effect until such time as the undersigned is no longer subject to the provisions of Section 16 of the Securities Exchange Act of 1934 with respect to securities of the Issuer. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 25th day of October, 2018. /s/ Harold Wiens